Amiodarone-induced thyrotoxicosis with thyroid papillary cancer in multinodular goiter: Case report

7Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.
Get full text

Abstract

To report a case of amiodarone-induced thyrotoxicosis (AIT) concomitant with thyroid cancer in multinodular goiter (MNG). Clinical Presentation and Intervention: A 61-year-old man treated with amiodarone for 5 years presented with mild sweating. He was found to have AIT simultaneously with thyroid papillary cancer and MNG. Administration of amiodarone was stopped, and he was treated with methimazole for AIT. Five weeks after the initial treatment, thyroid function normalized. Total thyroidectomy was considered to enable use of amiodarone again. Conclusion: This case showed that thyrotoxicosis, MNG and amiodarone may contribute to thyroid carcinogenesis. Amiodarone should be carefully commenced in cases with MNG. © 2011 S. Karger AG, Basel.

Cite

CITATION STYLE

APA

Inaba, H., Suzuki, S., Takeda, T., Kobayashi, S., Akamizu, T., & Komatsu, M. (2012). Amiodarone-induced thyrotoxicosis with thyroid papillary cancer in multinodular goiter: Case report. Medical Principles and Practice, 21(2), 190–192. https://doi.org/10.1159/000333697

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free